<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01592175</url>
  </required_header>
  <id_info>
    <org_study_id>C11-49</org_study_id>
    <secondary_id>2011-A01554-37</secondary_id>
    <nct_id>NCT01592175</nct_id>
  </id_info>
  <brief_title>Magnetoencephalography (MEG), Attention and Conscience</brief_title>
  <official_title>Spatio-temporal Dynamic of the Relationship Between Spatial Attention and Visual Awareness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The tight relationship between attention and conscious perception makes them difficult to&#xD;
      study in isolation and has led many scientists to closely link these two processes. However,&#xD;
      while some authors argue that conscious perception cannot occurs without attention,&#xD;
      magnetoencephalography (MEG) and fMRI studies had shown that attention and consciousness are&#xD;
      two distinct brain processes.&#xD;
&#xD;
      If endogenously triggered attention and consciousness are dissociated, it has been proposed&#xD;
      that orienting of exogenous attention is a necessary, though not sufficient, antecedent of&#xD;
      conscious perception.&#xD;
&#xD;
      In the present study we used MEG to explore the neural correlates of exogenous attention and&#xD;
      consciousness during visual processing.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 8, 2012</start_date>
  <completion_date type="Actual">July 2, 2013</completion_date>
  <primary_completion_date type="Actual">July 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Brain activity during visuo-spatial attention tasks</measure>
    <time_frame>Three years</time_frame>
    <description>Magnetoencephalography will be used to measured cerebral evoked potential and oscillatory activity, while subjects will performed a visuo-spatial attention task.</description>
  </primary_outcome>
  <enrollment type="Actual">32</enrollment>
  <condition>Change in Sustained Attention</condition>
  <condition>Awareness</condition>
  <condition>Reaction Time</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Young adults living in Paris or around fulfilling the eligibility criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects aged between 18 and 40 who have signed informed consent for participation to&#xD;
             the study and are affiliated to a social security regimen&#xD;
&#xD;
          -  right-handler, without auditory or visual deficit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of neurological or psychiatic disease&#xD;
&#xD;
          -  medication&#xD;
&#xD;
          -  sensory disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CRICM</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 16, 2012</study_first_submitted>
  <study_first_submitted_qc>May 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2012</study_first_posted>
  <last_update_submitted>August 27, 2021</last_update_submitted>
  <last_update_submitted_qc>August 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

